Style | Citing Format |
---|---|
MLA | Monajati M, et al.. "Clinical Effectiveness of a High Dose Versus the Standard Dose of Meropenem in Ventilator-Associated Pneumonia Caused by Multidrug-Resistant Bacteria: A Randomized, Single-Blind Clinical Trial." Infectious Disorders - Drug Targets, vol. 21, no. 2, 2021, pp. 280-289. |
APA | Monajati M, Ala S, Aliyali M, Ghasemian R, Heidari F, Ahanjan M, Moradi S, Sharifpour A, Mojtahedzadeh M, Salehifar E (2021). Clinical Effectiveness of a High Dose Versus the Standard Dose of Meropenem in Ventilator-Associated Pneumonia Caused by Multidrug-Resistant Bacteria: A Randomized, Single-Blind Clinical Trial. Infectious Disorders - Drug Targets, 21(2), 280-289. |
Chicago | Monajati M, Ala S, Aliyali M, Ghasemian R, Heidari F, Ahanjan M, Moradi S, Sharifpour A, Mojtahedzadeh M, Salehifar E. "Clinical Effectiveness of a High Dose Versus the Standard Dose of Meropenem in Ventilator-Associated Pneumonia Caused by Multidrug-Resistant Bacteria: A Randomized, Single-Blind Clinical Trial." Infectious Disorders - Drug Targets 21, no. 2 (2021): 280-289. |
Harvard | Monajati M et al. (2021) 'Clinical Effectiveness of a High Dose Versus the Standard Dose of Meropenem in Ventilator-Associated Pneumonia Caused by Multidrug-Resistant Bacteria: A Randomized, Single-Blind Clinical Trial', Infectious Disorders - Drug Targets, 21(2), pp. 280-289. |
Vancouver | Monajati M, Ala S, Aliyali M, Ghasemian R, Heidari F, Ahanjan M, et al.. Clinical Effectiveness of a High Dose Versus the Standard Dose of Meropenem in Ventilator-Associated Pneumonia Caused by Multidrug-Resistant Bacteria: A Randomized, Single-Blind Clinical Trial. Infectious Disorders - Drug Targets. 2021;21(2):280-289. |
BibTex | @article{ author = {Monajati M and Ala S and Aliyali M and Ghasemian R and Heidari F and Ahanjan M and Moradi S and Sharifpour A and Mojtahedzadeh M and Salehifar E}, title = {Clinical Effectiveness of a High Dose Versus the Standard Dose of Meropenem in Ventilator-Associated Pneumonia Caused by Multidrug-Resistant Bacteria: A Randomized, Single-Blind Clinical Trial}, journal = {Infectious Disorders - Drug Targets}, volume = {21}, number = {2}, pages = {280-289}, year = {2021} } |
RIS | TY - JOUR AU - Monajati M AU - Ala S AU - Aliyali M AU - Ghasemian R AU - Heidari F AU - Ahanjan M AU - Moradi S AU - Sharifpour A AU - Mojtahedzadeh M AU - Salehifar E TI - Clinical Effectiveness of a High Dose Versus the Standard Dose of Meropenem in Ventilator-Associated Pneumonia Caused by Multidrug-Resistant Bacteria: A Randomized, Single-Blind Clinical Trial JO - Infectious Disorders - Drug Targets VL - 21 IS - 2 SP - 280 EP - 289 PY - 2021 ER - |